TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04076241 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04076241 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01782287 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01181531 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00745719 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00545688 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00545688 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00559364 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02056067 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00913432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03334149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04568096 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04568096 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04568096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04568096 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02656043 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT02913131 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05127135 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT00637091 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00637091 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02094261 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02094261 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02266485 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02723877 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02723877 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT03305562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04552522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02875821 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04217785 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04217785 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02147990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02237547 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01056562 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01056562 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05750511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT02118610 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02304653 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04208763 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03273062 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00503113 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03507686 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT03280940 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT03280940 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03280940 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00585312 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04256707 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02508116 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01954914 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01957150 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00095862 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00095862 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03597438 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study NCT01070056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04028856 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04028856 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02951195 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02951195 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT00971113 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT02785627 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02785627 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01011556 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03616002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01967901 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01069796 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02600208 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04335188 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00261417 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00261417 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03566238 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT04561336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00468208 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT01701973 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01873339 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04314843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04314843 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01937117 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01937117 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01999088 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02846883 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04759534 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT00019734 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05440695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05770557 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02310763 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02761603 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02965664 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00071019 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00668096 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02919111 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01578772 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03130985 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT01058798 — Predictive Biomarker (PRD): B4GALNT3 mRNA
Genes: B4GALNT3
Study NCT01058798 — Predictive Biomarker (PRD): B4GALNT4 mRNA
Genes: B4GALNT4
Study NCT02758548 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03416439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06104150 — Predictive Biomarker (PRD): SLC16A1 mRNA
Genes: SLC16A1; MCT1
Study NCT00244829 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00244829 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00945217 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00945217 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02118285 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02373267 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT02993705 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00628082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03266952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00626847 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02400190 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01830517 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01473810 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01473810 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01784016 — Safety Biomarker (SAF): DRD3
Study NCT02719704 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00501163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03935841 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04439110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04347330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01417351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01540292 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01104909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02851732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01071031 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00075686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01684059 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03011060 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02853370 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT05714722 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT02547805 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04651920 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04651920 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04651920 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04271072 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01494103 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT00865449 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02542735 — Predictive Biomarker (PRD): VEGFB mRNA
Genes: VEGFB; VRF
Study NCT02542735 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04456933 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00387517 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04184934 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02023840 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04299776 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01958515 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00001887 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03817567 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06355830 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01784874 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01343498 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT03497819 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00705315 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03768349 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01446224 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03280641 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02176499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00378820 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04250883 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT01348204 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01348204 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT00056381 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00898820 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00898820 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT00898820 — Safety Biomarker (SAF): MTHFR
Study NCT01074645 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02079337 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT02256969 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT03793855 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03793855 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03793855 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03793855 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03793855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01687153 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03877926 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03818061 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03245307 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03245307 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03245307 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02724020 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02724020 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02130778 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00919178 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02508259 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT00279539 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00279539 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00279539 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05375331 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03431064 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01876368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04336384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04619550 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01606761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04638270 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00244179 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02389842 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02389842 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04407546 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03619876 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03619876 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT03801889 — Predictive Biomarker (PRD): Liver iron
Study NCT03667612 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03667612 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03594825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03156075 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03560908 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00935285 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT00935285 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02806687 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT04421755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04320719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04599621 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03754530 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00436917 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03346954 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03346954 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00929058 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03311555 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00695539 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02249117 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02334761 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02334761 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04703543 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03840070 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00690469 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT00690469 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT02304406 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00237419 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00706719 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT04440280 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02497131 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00330460 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03540849 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01009788 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01189435 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02588196 — Predictive Biomarker (PRD): LTA4H mRNA
Genes: LTA4H; LTA4
Study NCT04159194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01679080 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03064243 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02775578 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT02775578 — Predictive Biomarker (PRD): CCHCR1 mRNA
Genes: CCHCR1; C6orf18; HCR
Study NCT04021355 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00867048 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01220570 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03871374 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01505920 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00392782 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study NCT03629288 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02657005 — Predictive Biomarker (PRD): FLI1 mRNA
Genes: FLI1
Study NCT03635268 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00925756 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00925756 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05120024 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04238637 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04238637 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04222920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03899649 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02071056 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04202341 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT00383422 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00369655 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00369655 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01266616 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01266616 — Safety Biomarker (SAF): Interleukin 12
Study NCT03559335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03559335 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03559335 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study NCT00508027 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01185379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02908139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03242083 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01200979 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04034485 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01763281 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT00426530 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03367689 — Predictive Biomarker (PRD): Homologous recombination deficiency